title: [Clinical evaluation of enoxacin].
abstract: 436 patients with various infections were treated with 2 kinds of enoxacin preparations, tablets in 336 cases and capsules in 100 cases. The total effective rate for tablets and capsules was 97.0% and 95.0% respectively. The bacterial eradication rate was 96.8% for tablets and 96.7% for capsules. Adverse reactions were few and mild. A randomized study of enoxacin and norfloxacin in the treatment of 209 patients with enteric and urinary infections was carried out simultaneously, the effective rate of enoxacin (99.1%) was similar to norfloxacin (95.0%). The incidence of side effects in norfloxacin group was slightly higher than that in enoxacin (P less than 0.05).
authors.affiliation: Clinical Cooperation Group of Enoxacin Shanghai Huashan Hospital.
authors.forename: Y Y
authors.initials: YY
authors.lastname: Zhang
authors.forename: B Y
authors.initials: BY
authors.lastname: Zhun
authors.forename: S C
authors.initials: SC
authors.lastname: Jiang
mesh_terms: D000328:Adult; D004405:Dysentery, Bacillary / Q000188:drug therapy; D015365:Enoxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009643:Norfloxacin / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D014435:Typhoid Fever / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy
chemical_list: D015365:Enoxacin; D009643:Norfloxacin